Serial fecal ASCA measurements in the evaluation of children with Crohn's disease
BACKGROUND: Pediatric patients with Inflammatory Bowel Disease (IBD) undergo costly and invasive investigations to diagnose and treat their chronic disease. To that end, it is important for researchers and physicians to continue to work to find novel tools to improve diagnosis and treatment processe...
Main Author: | Mojdehbakhsh, Rachel |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/16025 |
Similar Items
-
Serial fecal biomarker measurements predict response to biologic therapy in children with IBD
by: Moxley, Erika Michelle
Published: (2019) -
Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease: A reappraisal of the role of S. cerevisiae in this setting
by: B. Sendid, et al.
Published: (2018-12-01) -
ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation
by: Naim Abu-Freha, et al.
Published: (2018-10-01) -
Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
by: Andrew S. Day, et al.
Published: (2017-06-01) -
Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
by: Fang Liu, et al.
Published: (2020-12-01)